Abstract 4141371: Comparing predictors of atrial fibrillation recurrence following <i>de novo</i> versus repeat catheter ablation

Background: Approximately 1 of 5 catheter ablations for atrial fibrillation (AF) are repeat procedures. Despite this, little is known about risk factors for recurrence in patients undergoing repeat ablation compared with those undergoing de novo ablation. Objective: To compare predictors of AF recurrence following de novo and repeat catheter ablation. Methods: To compare AF recurrence between those with and without prior ablation, we conducted a retrospective cohort study of patients undergoing catheter ablation for treatment of symptomatic and drug-refractory AF. In this analysis, early recurrence was defined as 30 seconds of AF, atrial flutter, or atrial tachycardia within a 3-month blanking period, while late recurrence was defined as recurrent arrhythmia at &gt;3 months. Multivariable Cox proportional hazard regression analysis was used to identify independent factors associated with recurrence. Results: Among 659 patients, 487 (mean age 63.3 +/- 10.1 years, 33% female, CHA2DS2-VASc 2.8 +/- 1.8, 62% paroxysmal) underwent de novo ablation and 172 (mean age 65.1 +/- 10.0 years, 34% female, CHA2DS2-VASc 3.1 +/- 1.9, 60% paroxysmal) underwent repeat ablation with average follow up of 24.4+/-18.4 months. Multivariable modeling revealed that left atrial volume index (LAVi) [HR 1.015, p&lt;0.0001], body mass index (BMI) [HR 1.025, p=0.043], and early recurrence [HR 2.496, p&lt;0.0001] were predictive of late recurrence in the de novo ablation cohort, compared to LAVi [HR 1.014, p=0.006] and early recurrence [HR 2.053, p=0.001] in the repeat ablation cohort. Age, sex, AF type (paroxysmal vs non-paroxysmal), obstructive sleep apnea, heart failure, CHA2DS2-VASc scores, and energy source (cryoballoon vs radiofrequency) were not predictive of recurrence in either cohort (p&gt;0.05). There was a trend towards higher probability of recurrence following repeat ablation (log-rank p=0.052). Conclusion: Predictors of late AF recurrence following de novo and repeat catheter ablation are similar at &gt;2 years follow-up. The left atrial volume index and early recurrence are the strongest predictors of late recurrence.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4141371
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4141371: Comparing predictors of atrial fibrillation recurrence following de novo versus repeat catheter ablation

Daniel J. Friedman, Hannah Schwennesen, Jonathan Paul Piccini, Mark Brahier et al.
Circulation
Atrial Fibrillation Management and Outcomes
article

Abstract 4141371: Comparing predictors of atrial fibrillation recurrence following de novo versus repeat catheter ablation

Daniel J. Friedman, Hannah Schwennesen, Jonathan Paul Piccini, Mark Brahier, Andrew Vista
article en

Abstract

Background: Approximately 1 of 5 catheter ablations for atrial fibrillation (AF) are repeat procedures. Despite this, little is known about risk factors for recurrence in patients undergoing repeat ablation compared with those undergoing de novo ablation. Objective: To compare predictors of AF recurrence following de novo and repeat catheter ablation. Methods: To compare AF recurrence between those with and without prior ablation, we conducted a retrospective cohort study of patients undergoing catheter ablation for treatment of symptomatic and drug-refractory AF. In this analysis, early recurrence was defined as 30 seconds of AF, atrial flutter, or atrial tachycardia within a 3-month blanking period, while late recurrence was defined as recurrent arrhythmia at &gt;3 months. Multivariable Cox proportional hazard regression analysis was used to identify independent factors associated with recurrence. Results: Among 659 patients, 487 (mean age 63.3 +/- 10.1 years, 33% female, CHA2DS2-VASc 2.8 +/- 1.8, 62% paroxysmal) underwent de novo ablation and 172 (mean age 65.1 +/- 10.0 years, 34% female, CHA2DS2-VASc 3.1 +/- 1.9, 60% paroxysmal) underwent repeat ablation with average follow up of 24.4+/-18.4 months. Multivariable modeling revealed that left atrial volume index (LAVi) [HR 1.015, p&lt;0.0001], body mass index (BMI) [HR 1.025, p=0.043], and early recurrence [HR 2.496, p&lt;0.0001] were predictive of late recurrence in the de novo ablation cohort, compared to LAVi [HR 1.014, p=0.006] and early recurrence [HR 2.053, p=0.001] in the repeat ablation cohort. Age, sex, AF type (paroxysmal vs non-paroxysmal), obstructive sleep apnea, heart failure, CHA2DS2-VASc scores, and energy source (cryoballoon vs radiofrequency) were not predictive of recurrence in either cohort (p&gt;0.05). There was a trend towards higher probability of recurrence following repeat ablation (log-rank p=0.052). Conclusion: Predictors of late AF recurrence following de novo and repeat catheter ablation are similar at &gt;2 years follow-up. The left atrial volume index and early recurrence are the strongest predictors of late recurrence.

CirculationVol. 150(Suppl_1)
Duke Medical Center (US)
Good health and well-being
Openalex Percentile: Top 62%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.